Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00958789 · ClinicalTrials.gov registry record · NA

Triathlon Total Stabilizer (TS) Outcomes Study

A NA study, sponsored by Stryker Orthopaedics.

Completed
Registry status
NA
Development phase
180
Enrollment target

NCT00958789: Completed NA study, sponsored by Stryker Orthopaedics.

NCT00958789 is a NA study that has completed, run by Stryker Orthopaedics. The registered enrollment target is 180 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00958789, a NA study, has completed, sponsored by Stryker Orthopaedics.

COMPLETED
Registry status
NA
Development phase
180 participants
Enrollment target

Study Summary

This study will be a prospective, non-randomized evaluation of the change between preoperative and postoperative outcomes for those receiving the Triathlon® TS Total Knee System for a revision knee operation. The mean total Knee Society Score (for pain, motion and function) change is not 10% worse than, or is superior to, the expected change according to published revision total knee replacement data, for cases implanted with the Triathlon® TS Total Knee System as compared from preoperative to 2 years postoperative.

Primary Outcome

KSS Pain score, KSS Function score, Total Combined KSS The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, range of motion (ROM) and joint stability, and one for functional parameters. Sub-scores range from a potential minimum score of 0 to a maximum score of 100 points. Although the specific scores are not distinguished as "excellent," "good," "fair," or "poor," a higher value represents a better outcome. Additionally, the KSS Pain subscore and KSS F

Interventions

  • DEVICE Triathlon TS Knee System

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2009-07
Est. Completion 2019-03-28
Phase NA
Stryker Orthopaedics

27 total trials

What the finished NCT00958789 record still lists

NCT00958789 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).

The record links to 0 conditions, and to 1 intervention - of which Triathlon TS Knee System is the first listed.

NCT00958789 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00958789 about?

NCT00958789 is a clinical study titled "Triathlon Total Stabilizer (TS) Outcomes Study". This study will be a prospective, non-randomized evaluation of the change between preoperative and postoperative outcomes for those receiving the Triathlon® TS Total Knee System for a revision knee operation. The mean total Knee Society Score (for pain, motion and function) change is not 10% worse t...

What is the current status of trial NCT00958789?

This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2009-07. Estimated completion is 2019-03-28.

What interventions are being tested in trial NCT00958789?

The interventions under investigation include: Triathlon TS Knee System (DEVICE).

Who is sponsoring clinical trial NCT00958789?

This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00958789's enrollment target sits among peer trials

180 586th of 2000 higher than 1,397 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01558804 · 180 participants

    GRoup A StrePtococcus

  • NCT02932176 · 180 participants

    Machine Learning for Handheld Vascular Studies

  • NCT03384563 · 180 participants · Phase 4

    Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane

  • NCT03423628 · 180 participants · Phase 1

    A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00958789, the US trial registry maintained by the National Library of Medicine. NCT00958789 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.